Dr. Decker leads our highly skilled team of researchers dedicated to applying cutting edge science to the immunotherapeutic treatment of cancer. He holds multiple patents on innovative technologies in the field of cancer vaccination. His vaccine technologies are the focus of two phase I clinical trials for intent to treat pediatric brain tumors and adult pancreatic cancer.
Publications/Creative Works
Click here to search for this faculty member's publications on PubMed.
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.